Different Immunochemotherapies in Small B-cell Non-Hodgkin Lymphoma (iNHL)

Fudan University

Status

Active, not recruiting

Conditions

Lymphoma, Non-Hodgkin

Treatments

Drug: immunochemotherapies

Study type

Observational

Funder types

Other

Identifiers

NCT06170216

iNHL-01

Details and patient eligibility

About

Describe the application status of different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL), observe the therapeutic efficacy and safety of the treatment modalities.

Full description

Evaluated the efficacy and safety of different immunochemotherapies in small B-cell non-Hodgkin lymphoma (iNHL)

Enrollment

220 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Age ≥ 18 years old
Initial or first recurrent iNHL confirmed by histopathology, including FL (1-3a), MZL, MCL;
Sign an informed consent form;
Researchers evaluate patients who can benefit from receiving immunochemotherapy.

Exclusion criteria

There are contraindications to any medication in the treatment plan;
Pregnant or lactating women or male and female participants of childbearing age did not take contraceptive measures during the trial period and within 30 days after the last medication;
Researchers believe that patients who are not suitable for enrollment.